You have 9 free searches left this month | for more free features.

Lymphoma

Showing 1 - 25 of 8,896

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,

Suspended
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +23 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 23, 2022

B-Cell Non-Hodgkin Lymphoma, DLBCL, Not Otherwise Specified, High Grade B-Cell Lymphoma Trial in Seattle (Acalabrutinib,

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 16, 2022

Lymphoma, Non-Hodgkin Lymphoma, B-Cell Trial (BAFF CAR-T)

Not yet recruiting
  • Lymphoma, Non-Hodgkin Lymphoma, B-Cell
  • BAFF CAR-T
  • (no location specified)
Aug 16, 2022

Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Buparlisib, Ibrutinib)

Active, not recruiting
  • Lymphoma
  • +3 more
  • Basking Ridge, New Jersey
  • +5 more
Jun 13, 2022

Lymphoma, Survivorship Trial in Boston (Interview with Clinicians, Field Test of UPLYFT with Lymphoma Survivors, Pilot of UPLYFT

Recruiting
  • Lymphoma
  • Survivorship
  • Interview with Clinicians
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 14, 2022

Lymphoma Trial (Tislelizumab)

Not yet recruiting
  • Lymphoma
  • (no location specified)
Jul 28, 2022

Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial run by the NCI (Obinutuzumab, Venetoclax, Magrolimab)

Recruiting
  • Follicular Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 20, 2022

Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma, Recurrent Follicular T-Cell

Recruiting
  • Recurrent Angioimmunoblastic T-Cell Lymphoma
  • +13 more
  • Brentuximab Vedotin
  • Pembrolizumab
  • Chicago, Illinois
    Northwestern University
Jun 15, 2022

Cardiovascular Events Among Adults Relapsed or Refractory

Recruiting
  • Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma
  • +9 more
  • Electronic Health Record Review
  • Houston, Texas
    M D Anderson Cancer Center
May 24, 2022

Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Palo Alto (Ibrutinib, Radiation

Active, not recruiting
  • Grade 1 Follicular Lymphoma
  • +6 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jun 13, 2022

PET/CT Vs BMB in Exclusion of BM Infiltration for Initial

Not yet recruiting
  • Lymphoma
  • positron emission tomography for exclusion of bone marrow infiltration in lymphoma
  • (no location specified)
Sep 30, 2022

Diffuse Large B-cell Lymphoma Trial in Toulouse (Patient with histologically confirmed diffuse large B-cell lymphoma with a

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Patient with histologically confirmed diffuse large B-cell lymphoma with a planned first line treatment by R-CHOP.
  • Toulouse, France
    Institut Universitaire du Cancer Toulouse - Oncopole
Mar 28, 2022

Lymphoma Trial in Boston (3RP-Lymphoma)

Completed
  • Lymphoma
  • 3RP-Lymphoma
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 9, 2021

B-Cell Lymphoma, B Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Pittsburgh (Chimeric Antigen Receptor

Recruiting
  • B-Cell Lymphoma
  • +8 more
  • Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
  • Pittsburgh, Pennsylvania
    AHN Cancer Institute - West Penn Hospital
Aug 10, 2022

Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Lymphoma Trial in Hangzhou (RD14-01 cell infusion)

Recruiting
  • Mantle Cell Lymphoma
  • +2 more
  • RD14-01 cell infusion
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Jul 6, 2022

B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

Not yet recruiting
  • B-cell Non-Hodgkin Lymphoma
  • +4 more
  • (no location specified)
May 6, 2022

Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders Trial (Zilovertamab, Ibrutinib, Placebo)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • +7 more
  • (no location specified)
Jun 21, 2022

Anaplastic Large Cell Lymphoma, Peripheral T Cell Lymphoma, Extranodal NK/T-cell Lymphoma Trial in Duarte, Nashville, Houston

Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Duarte, California
  • +3 more
Jul 21, 2022

Hodgkin Lymphoma, NK/T Cell Lymphoma, Peripheral T Cell Lymphoma, Unspecified Trial in Hangzhou (Anti CD30 CAR-T Cell Injection)

Not yet recruiting
  • Hodgkin Lymphoma
  • +7 more
  • Anti CD30 CAR-T Cell Injection
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of medicine, Zhejiang Uni
Jan 12, 2022

Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma Trial in Seoul

Completed
  • Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma
    • Seoul, Gangnam-Gu, Korea, Republic of
      Samsung Medical Center
    Feb 4, 2022

    Burkitt's Lymphoma, Burkitt's Leukemia, Mediastinal Tumors Trial in Frankfurt (Adriamycin, Cyclophosphamide, Cytarabine)

    Completed
    • Burkitt's Lymphoma
    • +4 more
    • Frankfurt, Germany
      University Hospital, Medical Dept. II
    Aug 17, 2022

    A Study of People With CD30 Positive Lymphoma in China

    Not yet recruiting
    • Lymphoma
      • (no location specified)
      Aug 17, 2022

      Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)

      Recruiting
      • Lymphoma
      • +4 more
      • Pharmacokinetics
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Sep 12, 2022

      Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the National Cancer Institute (NCI) (Venetoclax, Ibrutinib, Prednisone)

      Recruiting
      • Lymphoma
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 20, 2022

      AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Non-Hodgkin Lymphoma, HIV Infection Trial (Axicabtagene Ciloleucel,

      Not yet recruiting
      • AIDS-Related Diffuse Large B-cell Lymphoma
      • +14 more
      • Axicabtagene Ciloleucel
      • +2 more
      • (no location specified)
      Feb 15, 2022